Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05344209
Title Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer (LUNGVAC)
Acronym LUNGVAC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vestre Viken Hospital Trust
Indications
Therapies
Age Groups: senior | adult
Covered Countries


No variant requirements are available.